Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D F Ma

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
BMC Medical Genomics|April 2, 2011
Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingTo Ha Loi, Anna Campain, Adam Bryant, et al.
Frontiers in Immunology|February 7, 2022
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell TransplantationKevin Hendrawan, Melissa L M Khoo, Malini Visweswaran, et al.
Leukemia & Lymphoma|August 26, 2011
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcomeIan Nivison-Smith, Anthony J Dodds, Richard Doocey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004Ian Nivison-Smith, Kenneth F Bradstock, Anthony J Dodds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 1, 2017
Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New ZealandIan Nivison-Smith, Samuel Milliken, Anthony J Dodds, et al.
Annals of Clinical and Translational Neurology|February 2, 2022
Sustained immunotolerance in multiple sclerosis after stem cell transplantMalini Visweswaran, Kevin Hendrawan, Jennifer C Massey, et al.
Internal Medicine Journal|November 1, 2020
Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experienceIan Nivison-Smith, Ashish Bajel, Anthony J Dodds, et al.
Bone Marrow Transplantation|May 26, 2018
Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysisChun Kei Kris Ma, Irene García-Cadenas, María Laura Fox, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2018
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosisJohn J Moore, Jennifer C Massey, Carole D Ford, et al.
The Lancet. Haematology|January 16, 2019
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a studyAnas Younes, Joshua Brody, Cecilia Carpio, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
BMC Medical Genomics|April 2, 2011
Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingTo Ha Loi, Anna Campain, Adam Bryant, et al.
Frontiers in Immunology|February 7, 2022
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell TransplantationKevin Hendrawan, Melissa L M Khoo, Malini Visweswaran, et al.
Leukemia & Lymphoma|August 26, 2011
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcomeIan Nivison-Smith, Anthony J Dodds, Richard Doocey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004Ian Nivison-Smith, Kenneth F Bradstock, Anthony J Dodds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 1, 2017
Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New ZealandIan Nivison-Smith, Samuel Milliken, Anthony J Dodds, et al.
Annals of Clinical and Translational Neurology|February 2, 2022
Sustained immunotolerance in multiple sclerosis after stem cell transplantMalini Visweswaran, Kevin Hendrawan, Jennifer C Massey, et al.
Internal Medicine Journal|November 1, 2020
Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experienceIan Nivison-Smith, Ashish Bajel, Anthony J Dodds, et al.
Bone Marrow Transplantation|May 26, 2018
Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysisChun Kei Kris Ma, Irene García-Cadenas, María Laura Fox, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2018
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosisJohn J Moore, Jennifer C Massey, Carole D Ford, et al.
The Lancet. Haematology|January 16, 2019
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a studyAnas Younes, Joshua Brody, Cecilia Carpio, et al.
Pageof 4